Gold prices slide further as easing US-China tensions curb haven demand
PLEASANTON, Calif. - 10x Genomics, Inc. (NASDAQ:TXG), a life sciences company generating annual revenue of $644 million with an impressive 70% gross profit margin, and AI company Anthropic announced Monday a collaboration to integrate 10x’s analysis tools into Anthropic’s Claude for Life Sciences offering through the Model Context Protocol.
The partnership aims to make complex single cell and spatial biology analysis accessible through natural language conversations rather than requiring specialized coding knowledge. Researchers can now perform analytical tasks like read alignment, clustering, and secondary analysis by asking questions in plain English.
"Now, researchers can begin to interact with their data through natural conversation, without needing a computational background," said Serge Saxonov, Co-Founder and CEO of 10x Genomics.
The integration allows scientists to directly interact with their own 10x datasets through Claude for Life Sciences. By incorporating 10x’s Cloud Analysis capabilities, the system supports both new users and advanced research teams conducting large-scale analyses.
Eric Kauderer-Abrams, Head of Life Sciences and Biology at Anthropic, noted that the collaboration demonstrates "what’s possible when we remove the technical barriers that have limited access to the analysis tools that labs run on."
The companies indicated this marks the beginning of broader efforts to make 10x single cell and spatial analysis more intuitive through AI integration. The announcement was made in a press release statement from both companies.
10x Genomics develops integrated research solutions for single cell and spatial biology, while Anthropic is known for its AI assistant Claude, which is now being specialized for scientific applications.
In other recent news, 10x Genomics reported a notable earnings surprise for the second quarter of 2025, with an earnings per share of $0.28, surpassing the forecast of -$0.37. The company also exceeded revenue expectations, achieving $173 million, which is 24.03% above what was anticipated. These financial results highlight a strong performance for the period. Additionally, 10x Genomics announced a partnership with AI company Anthropic to integrate its single cell and spatial analysis tools into Anthropic’s Claude for Life Sciences platform. This collaboration aims to enhance accessibility for researchers through natural language interaction. Piper Sandler initiated coverage on 10x Genomics with a Neutral rating, setting a price target of $15.00. The research firm recognized 10x Genomics’ leading position in the single cell market and its technological advantages. These developments reflect recent strategic and financial activities for the company.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.